Author:
Marchant Colin D.,Miller Jacqueline M.,Marshall Gary S.,Blatter Mark,Aris Emmanuel,Friedland Leonard R.,Boutriau Dominique
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Infectious Diseases,Microbiology (medical),Pediatrics, Perinatology and Child Health
Reference31 articles.
1. Surveillance for meningococcal disease and strategies for use of conjugate meningococcal vaccines in the United States.;Lingappa;Vaccine,2001
2. Notice to readers: revised recommendations of the Advisory Committee on Immunization Practices to vaccinate all persons aged 11–18 years with Meningococcal Conjugate Vaccine.;MMWR,2007
3. Notice to readers: recommendation from the Advisory Committee on Immunization Practices (ACIP) for use of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in children aged 2–10 years at increased risk for invasive meningococcal disease.;MMWR,2007
4. Use of combination vaccines is associated with improved coverage rates.;Marshall;Pediatr Infect Dis J,2007
5. The use of combination vaccines has improved the timeliness of vaccination in children.;Kalies;Pediatr Infect Dis J,2006